Speaking topic: Ketamine and Psilocybin: How Do Psychedelics Work?
Matt Emmer is the VP of Healthcare Practice at Field Trip Health. He is also a co-founder of the Psykia Institute, which works to advance frameworks around integrative holotropic therapies. Prior to joining Field Trip, Matt was a VP at HNA Capital International, where he executed principal investments and helped establish HNA’s Hainan Cihang Charity Foundation. He spent time as an investment banker at Bank of America Merrill Lynch and Deutsche Bank, and at Ceniarth, a London-based social impact investment fund. Matt received his bachelor’s in Applied Mathematics from UCLA and completed the Executive Education Program at Columbia Business School. Matt’s personal exploration of plant medicines and consciousness sparked a passion to help share these healing modalities with others in safe and empowering settings. Field Trip Health is a global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics and our Field Trip Health division building centers for psychedelic therapies opening across North America and Europe along with the digital and technological tools that will enable massive scale, we help people in need with a simple, evidence-based way to heal and heighten engagement with the world.